Edition:
United States

Quotient Ltd (QTNT.OQ)

QTNT.OQ on NASDAQ Stock Exchange Global Market

4.43USD
8 Dec 2017
Change (% chg)

$-0.15 (-3.28%)
Prev Close
$4.58
Open
$4.62
Day's High
$4.62
Day's Low
$4.40
Volume
25,198
Avg. Vol
76,833
52-wk High
$7.72
52-wk Low
$3.22

Chart for

About

Quotient Limited is a diagnostics company. The Company focuses on blood grouping and donor disease screening, which is referred to as transfusion diagnostics. It is engaged in developing, manufacturing and commercializing conventional reagent products used for blood grouping within the global transfusion diagnostics market. It... (more)

Overall

Beta: 1.45
Market Cap(Mil.): $201.83
Shares Outstanding(Mil.): 45.56
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 57.47 15.67
EPS (TTM): -- -- --
ROI: -- 13.36 34.62
ROE: -- 20.03 16.00

BRIEF-Highbridge Capital Management reports 9.92 pct passive stake in Quotient Ltd

* Highbridge Capital Management Llc reports 9.92 percent passive stake in Quotient Ltd as on October 24 - SEC filing Source text: (http://bit.ly/2y47agF) Further company coverage:

Oct 25 2017

BRIEF-Quotient reports positive concordance data from Mosaiq platform

* Quotient reports positive concordance data from Mosaiq verification and validation studies for blood grouping and announces financing

Oct 25 2017

BRIEF-Quotient Limited announces $40 million private placement

* Quotient Limited announces $40 million private placement and the issue of warrants to raise up to an additional $49 million

Oct 25 2017

BRIEF-Quotient Ltd says sent a form of email to certain shareholders of co

* Quotient Ltd says sent a form of email to certain shareholders of co in connection with co's 2017 annual general meeting of shareholders - SEC filing

Oct 11 2017

Earnings vs. Estimates